ADMA BIOLOGICS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adma Biologics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Adma Biologics, Inc. Return On Equity for the quarter ending September 30, 2024 was 38.4 %.
  • Adma Biologics, Inc. annual Return On Equity for 2023 was -19.5 %, a 63.5% increase from 2022.
  • Adma Biologics, Inc. annual Return On Equity for 2022 was -53.4 %, a 12.8% increase from 2021.
  • Adma Biologics, Inc. annual Return On Equity for 2021 was -61.2 %, a 32.7% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -19.5 +33.9 +63.5% Jan 1, 2023 Dec 31, 2023
2022 -53.4 +7.83 +12.8% Jan 1, 2022 Dec 31, 2022
2021 -61.2 +29.8 +32.7% Jan 1, 2021 Dec 31, 2021
2020 -91 +70.9 +43.8% Jan 1, 2020 Dec 31, 2020
2019 -162 +37.7 +18.9% Jan 1, 2019 Dec 31, 2019
2018 -200 +49.6 +19.9% Jan 1, 2018 Dec 31, 2018
2017 -249 -2.17K -113% Jan 1, 2017 Dec 31, 2017
2016 1.92K +2.17K Jan 1, 2016 Dec 31, 2016
2015 -251 -95.8 -61.9% Jan 1, 2015 Dec 31, 2015
2014 -155 +59.7 +27.8% Jan 1, 2014 Dec 31, 2014
2013 -214 -158 -278% Jan 1, 2013 Dec 31, 2013
2012 -56.8 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.